Cargando…
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...
Autores principales: | Kim, Michael D., Baumlin, Nathalie, Dennis, John S., Yoshida, Makoto, Kis, Adrian, Aguiar, Carolina, Schmid, Andreas, Mendes, Eliana, Salathe, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836504/ https://www.ncbi.nlm.nih.gov/pubmed/33532463 http://dx.doi.org/10.1183/23120541.00394-2020 |
Ejemplares similares
-
Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction
por: Kim, Michael D., et al.
Publicado: (2022) -
Association of the CFTR gene with asthma and airway mucus hypersecretion
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2021) -
Role of Smad3 and p38 Signalling in Cigarette Smoke-induced CFTR and BK dysfunction in Primary Human Bronchial Airway Epithelial Cells
por: Sailland, Juliette, et al.
Publicado: (2017) -
Discovery of a drug to treat airway mucus hypersecretion
por: Dickey, Burton F., et al.
Publicado: (2022) -
Amelioration of Cigarette Smoke-Induced Mucus Hypersecretion and Viscosity by Dendrobium officinale Polysaccharides In Vitro and In Vivo
por: Chen, Rui, et al.
Publicado: (2020)